Initially, CCDC3 mRNA level was found to be induced upon INZ treatment of p53+/+ HCT116 colon cancer cells (Supplementary Fig. 1a), suggesting that CCDC3 might be a potential p53 target. Here, CCDC3 is linked to colonic neoplasm.